These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31700121)

  • 1. Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer.
    Zhu G; Foletti D; Liu X; Ding S; Melton Witt J; Hasa-Moreno A; Rickert M; Holz C; Aschenbrenner L; Yang AH; Kraynov E; Evering W; Obert L; Lee C; Sai T; Mistry T; Lindquist KC; Van Blarcom T; Strop P; Chaparro-Riggers J; Liu SH
    Sci Rep; 2019 Nov; 9(1):16735. PubMed ID: 31700121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer.
    Zhu G; Foletti D; Liu X; Ding S; Melton Witt J; Hasa-Moreno A; Rickert M; Holz C; Aschenbrenner L; Yang AH; Kraynov E; Evering W; Obert L; Lee C; Sai T; Mistry T; Lindquist KC; Van Blarcom T; Strop P; Chaparro-Riggers J; Liu SH
    Sci Rep; 2019 Jun; 9(1):8420. PubMed ID: 31182754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author Correction: Phosphoinositides regulate the TCR/CD3 complex membrane dynamics and activation.
    Chouaki Benmansour N; Ruminski K; Sartre AM; Phelipot MC; Salles A; Bergot E; Wu A; Chicanne G; Fallet M; Brustlein S; Billaudeau C; Formisano A; Mailfert S; Payrastre B; Marguet D; Brasselet S; Hamon Y; He HT
    Sci Rep; 2020 Jul; 10(1):12558. PubMed ID: 32704037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.
    Peng W; Zhou Z; Zhong Y; Sun Y; Wang Y; Zhu Z; Jiao W; Bai M; Sun J; Lu J; Yin H
    Sci Rep; 2020 Oct; 10(1):17254. PubMed ID: 33057092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.
    Chan-Seng-Yue M; Kim JC; Wilson GW; Ng K; Figueroa EF; O'Kane GM; Connor AA; Denroche RE; Grant RC; McLeod J; Wilson JM; Jang GH; Zhang A; Liang SB; Borgida A; Chadwick D; Kalimuthu S; Lungu I; Bartlett JMS; Krzyzanowski PM; Sandhu V; Tiriac H; Froeling FEM; Karasinska JM; Topham JT; Renouf DJ; Schaeffer DF; Jones SJM; Marra MA; Laskin J; Chetty R; Stein LD; Zogopoulos G; Haibe-Kains B; Campbell PJ; Tuveson DA; Knox JJ; Fischer SE; Gallinger S; Notta F
    Nat Genet; 2020 Apr; 52(4):463. PubMed ID: 32051610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author Correction: Structural basis for delta cell paracrine regulation in pancreatic islets.
    E Drigo RA; Jacob S; García-Prieto CF; Zheng X; Fukuda M; Nhu HTT; Stelmashenko O; Peçanha FLM; Rodriguez-Diaz R; Bushong E; Deerinck T; Phan S; Ali Y; Leibiger I; Chua M; Boudier T; Song SH; Graf M; Augustine GJ; Ellisman MH; Berggren PO
    Nat Commun; 2019 Sep; 10(1):4218. PubMed ID: 31511521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Author Correction: Comparative analysis of HER2 copy number between plasma and tissue samples in gastric cancer using droplet digital PCR.
    Kim B; Nam SK; Seo SH; Park KU; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
    Sci Rep; 2020 May; 10(1):8355. PubMed ID: 32415289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Author Correction: Rectosigmoidal manifestations of venous malformations: MR imaging findings and interdisciplinary therapeutic modalities.
    Brill R; Brill E; Uller W; Teusch V; Gufler H; Hammer S; Fellner C; Evert K; Goldann C; Helm M; Rosendahl J; Wohlgemuth WA
    Sci Rep; 2020 Feb; 10(1):2458. PubMed ID: 32034240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Author Correction: Verbascoside: Identification, Quantification, and Potential Sensitization of Colorectal Cancer Cells to 5-FU by Targeting PI3K/AKT Pathway.
    Attia YM; El-Kersh DM; Wagdy HA; Elmazar MM
    Sci Rep; 2019 Dec; 9(1):18659. PubMed ID: 31796874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Author Correction: ATAC-seq reveals alterations in open chromatin in pancreatic islets from subjects with type 2 diabetes.
    Bysani M; Agren R; Davegårdh C; Volkov P; Rönn T; Unneberg P; Bacos K; Ling C
    Sci Rep; 2020 Jan; 10(1):1744. PubMed ID: 31996742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Author Correction: Targeting cardiac fibrosis with engineered T cells.
    Aghajanian H; Kimura T; Rurik JG; Hancock AS; Leibowitz MS; Li L; Scholler J; Monslow J; Lo A; Han W; Wang T; Bedi K; Morley MP; Saldana RAL; Bolar NA; McDaid K; Assenmacher CA; Smith CL; Wirth D; June CH; Margulies KB; Jain R; Puré E; Albelda SM; Epstein JA
    Nature; 2019 Dec; 576(7785):E2. PubMed ID: 31723271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author Correction: Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis.
    Kemi N; Eskuri M; Kauppila JH
    Sci Rep; 2020 Mar; 10(1):5183. PubMed ID: 32179847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author Correction: piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis.
    Li F; Yuan P; Rao M; Jin CH; Tang W; Rong YF; Hu YP; Zhang F; Wei T; Yin Q; Liang T; Wu L; Li J; Li D; Liu Y; Lou W; Zhao S; Liu MF
    Nat Cell Biol; 2020 Jun; 22(6):751. PubMed ID: 32296165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Author Correction: Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
    Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
    Cell Res; 2019 Sep; 29(9):777. PubMed ID: 31409908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.
    Xu J; Liu Y; Li Y; Wang H; Stewart S; Van der Jeught K; Agarwal P; Zhang Y; Liu S; Zhao G; Wan J; Lu X; He X
    Nat Nanotechnol; 2020 Apr; 15(4):342. PubMed ID: 31953520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author Correction: CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake.
    Kobayashi N; Okazaki S; Sampetrean O; Irie J; Itoh H; Saya H
    Sci Rep; 2020 Apr; 10(1):6084. PubMed ID: 32242056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author Correction: Inhibition of translation termination by small molecules targeting ribosomal release factors.
    Ge X; Oliveira A; Hjort K; Bergfors T; Gutiérrez-de-Terán H; Andersson DI; Sanyal S; Åqvist J
    Sci Rep; 2020 Mar; 10(1):4950. PubMed ID: 32170142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
    Luszczak S; Simpson BS; Stopka-Farooqui U; Sathyadevan VK; Echeverria LMC; Kumar C; Costa H; Haider A; Freeman A; Jameson C; Ratynska M; Ben-Salha I; Sridhar A; Shaw G; Kelly JD; Pye H; Gately KA; Whitaker HC; Heavey S
    Sci Rep; 2020 Nov; 10(1):19870. PubMed ID: 33177621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Author Correction: Cyclocarya paliurus tea leaves enhances pancreatic β cell preservation through inhibition of apoptosis.
    Xiao HT; Wen B; Ning ZW; Zhai LX; Liao CH; Lin CY; Mu HX; Bian ZX
    Sci Rep; 2020 Nov; 10(1):19446. PubMed ID: 33149142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort.
    Su YY; Chiang NJ; Tsai HJ; Yen CJ; Shan YS; Chen LT
    Sci Rep; 2020 Nov; 10(1):20199. PubMed ID: 33188263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.